R2 Technology PMA submission for ImageChecker mammogram analyzer expected by year end, firm says.
This article was originally published in The Gray Sheet
Executive Summary
R2 TECHNOLOGY IMAGECHECKER MAMMOGRAM ANALYZER PMA SUBMISSION is expected by "fall to early winter," James Pell, R2's president and CEO, told investors at the March 6 UBS Securities women's health conference in New York City. The system, intended to serve as a second reader of mammograms following initial review by a radiologist, could "significantly" reduce the number of detectable breast cancers missed during routine screening, Pell said.